Facial Injectables Market size is estimated to cross USD 36 Billion by the end of 2033, growing at a CAGR of 10% during the forecast period, i.e., 2023-2033. In the year 2022, the industry size of facial injectables was USD 18 Billion.The growth of the market can be attributed to the growing concern of people for physical appearance in every age group of people and the rapidly rising beauty industry. According to an estimate in 2021, adults under 25 around the world worry about their appearance for more than an hour and a half every day, which equates to 26 days a year.
Facial injectables are proven to be effective in eliminating wrinkles. With growing age wrinkles are the most common condition people face. Hence growing aging population is expected to boost the market further. As per an estimate, in 2019, there were 703 million people worldwide who were 65 or older. With the recent urbanization, there has been significant growth in terms of the aesthetic beauty of the human body, which has resulted in increased consciousness about enhanced physical appearance and opting for cosmetic procedures. Thus, the rising beauty standards among the population are expected to increase the sales of facial injectables in the upcoming years. In addition, the escalating preference for minimally invasive cosmetic procedures such as facial injectables owing to their better safety and requirement of little to no delay is also anticipated to boost the facial injectables market growth. Furthermore, the surge of investments by the prominent players of the market in various R&D initiatives to develop novel facial injectables to meet consumer demand is expected to contribute positively to market growth.
Base Year |
2022 |
Forecast Year |
2023-2033 |
CAGR |
~10% |
Base Year Market Size (2022) |
~USD 18 Billion |
Forecast Year Market Size (2033) |
~USD 36 Billion |
Regional Scope |
|
Growth Drivers
Challenges
Application (Wrinkle Reduction, Facelift, Acne Scar Treatment, Lipoatrophy Treatment, Lip Enhancement)
The global facial injectables market is segmented and analyzed for demand and supply by application into wrinkle reduction, facelift, acne scar treatment, lipoatrophy treatment, and lip enhancement. Out of which, the lip enhancement segment is estimated to garner the largest revenue by the end of 2033, backed by increasing demand for aesthetic enhancement of lips, growing concern for appearance, rising beauty standards, and rapid boost in the cosmetic sector. According to an estimate, approximately 2 million lip filler procedures were performed by the healthcare profession in the year 2018 across the globe. On the other hand, the wrinkle reduction segment is also expected to hold a significant share during the forecast period. The major factor attributed to segment growth is the burgeoning aging population’s need for wrinkle treatment. Also, the launch of novel wrinkle reduction products coupled with various expenditures for aesthetic procedures to restore the lost glow of the facial areas.
End-user (Hospitals, Specialty Clinics, Dermatology & Beauty Clinics)
The global facial injectables market is also segmented and analyzed for demand and supply by end-user into hospitals, specialty clinics, and dermatology & beauty clinics. Out of these, the dermatology & beauty clinics segment is projected to hold the largest share by 2033. A large number of facial injectables are being used in aesthetic procedures that are conducted in dermatology & beauty clinics. Furthermore, the presence of novel and advanced facial injectables present in the dermatology & beauty clinic settings is expected to expand the size of the segment. Other than that, the hospitals segment is also attributed to holding a significant share during the forecast period. The rising number of hospital admissions owing to burn incidents, accidents, traumatic cases, and injuries is leading to a high utilization rate of facial injectables in the treatment process.
Our in-depth analysis of the global market includes the following segments:
By Product |
|
By Application |
|
By End User |
|
The Asia Pacific facial injectables market, amongst the market in all the other regions, is projected to hold the largest revenue share by the end of 2033. The growth of the market can be attributed majorly to the increasing disposable income in the region, high expenditure on cosmetic surgery, increasing awareness about appearance, and rising beauty standards. For instance, Singapore's anticipated disposable income per capita within the ASEAN region was expected to be roughly around 30 thousand dollars in 2021. The strong demand for aesthetic procedures such as enhancing facial features from every age group and the burgeoning population is anticipated to create a positive outlook for market expansion. Further, the presence of major key players in the region along with their new product launches is expected to create a strong demand for facial injectables in dermatology and beauty clinics.
To improve the hydration, elasticity, and firmness of the skin as well as the appearance of fine lines, Merz Pharma, a world authority in medical aesthetics, has introduced Belotero Revive, a dermal filler product. It contains a special blend of hyaluronic acid (HA) and glycerol.
Ipsen Pharma announced that it will invest in a brand-new, cutting-edge electronic autoinjector for Somatuline Autogel/Somatuline Depot (lanreotide), bringing the category even further into the future and enhancing patient administration and injection experiences
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?